VOYA Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-227,917
| Closed | -$18.5M | – | 2751 |
|
|
2025
Q1 | $18.5M | Sell |
227,917
-84,346
| -27% | -$6.84M | 0.02% | 545 |
|
|
2024
Q4 | $28.1M | Buy |
312,263
+6,087
| +2% | +$548K | 0.03% | 447 |
|
|
2024
Q3 | $30.3M | Buy |
306,176
+37,196
| +14% | +$3.67M | 0.03% | 447 |
|
|
2024
Q2 | $24.9M | Buy |
268,980
+7,394
| +3% | +$685K | 0.02% | 473 |
|
|
2024
Q1 | $24.8M | Buy |
261,586
+22,338
| +9% | +$2.12M | 0.02% | 483 |
|
|
2023
Q4 | $21.4M | Buy |
239,248
+57,299
| +31% | +$5.12M | 0.02% | 507 |
|
|
2023
Q3 | $13.3M | Buy |
181,949
+1,002
| +0.6% | +$73.2K | 0.01% | 617 |
|
|
2023
Q2 | $15.1M | Buy |
180,947
+18,771
| +12% | +$1.56M | 0.02% | 601 |
|
|
2023
Q1 | $12.4M | Sell |
162,176
-71,292
| -31% | -$5.43M | 0.01% | 660 |
|
|
2022
Q4 | $19.4M | Buy |
233,468
+3,175
| +1% | +$264K | 0.02% | 544 |
|
|
2022
Q3 | $18.3M | Buy |
230,293
+870
| +0.4% | +$69K | 0.02% | 527 |
|
|
2022
Q2 | $17M | Buy |
229,423
+20,265
| +10% | +$1.51M | 0.04% | 357 |
|
|
2022
Q1 | $18.8M | Buy |
+209,158
| New | +$18.8M | 0.04% | 378 |
|